Industries > Pharma > Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029

Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029

Retinal Disorder Drugs, Allergic, Inflammatory & Infective Drugs, Glaucoma Drugs, Dry Eye Drugs

PUBLISHED: 15 August 2019
PAGES: 215
PRODUCT CODE: PHA0465
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0465 Categories: , Tags: , , ,

The global ophthalmic drugs market was valued at $25bn in 2018. The market was dominated by the Retinal Disorder drug submarket which held 43% of the global ophthalmic drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 215-page report you will receive 83 tables and 72 figures– all unavailable elsewhere.

The 215-page report provides clear detailed insight into the top ophthalmic drugs manufacturers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global ophthalmic drugs market revenue forecasts from 2019-2029

• Global ophthalmic drugs market revenue forecasts from 2019-2029, by submarket:
• Retinal Disorder Drugs
• Allergic, Inflammatory & Infective Drugs
• Glaucoma Drugs
• Dry Eye Drugs
• Other Ophthalmic Drugs

• Revenue forecasts from 2019-2028 of the leading ophthalmic drugs:
• Alphagan
• Avastin
• Azopt
• Eylea
• Lucentis
• Lumigan & Ganfort
• Restasis
• Vigamix
• Xalatan/Xalacom
• Other Ophthalmic Drugs

• Our report provides an overview, revenue forecast from 2019-2029 of the ophthalmic drugs segment, revenue forecast from 2019-2029 of the leading drugs, product pipeline and SWOT analysis, for these companies:
• Akorn
• Allergan
• Bayer
• Novartis
• Pfizer
• Regeneron
• Roche
• Santen Pharmaceuticals
• Senju
• Valeant

Top 30 Ophthalmic Drug Manufacturers 2019-2029

• Our study discusses the selected emerging ophthalmic drug manufacturers:
• Acucela
• Aerie Pharmaceuticals
• Aerpio Therapeutics
• Alimera Sciences
• Amakem
• Ampio Pharmaceuticals
• Chengdu Kanghong Pharmaceutical
• Eleven Biotherapeutics
• EyeGate Pharmaceuticals
• Gene Signal
• Icon Bioscience
• MacuCLEAR
• Neurotech
• Omeros
• OphthaliX /Can-Fite BioPharma
• Ophthotech
• Otsuka Pharmaceutical
• pSivida Corp.
• RXi Pharmaceuticals
• Shire
• ThromboGenics

• Our report provides these Qualitative Analysis:
• Drivers and Restraints of the Global Ophthalmic Drugs market
• SWOT Analysis of selected leading companies
• Porter’s Five Forces Analysis of the Global Ophthalmic Drugs Market

• Key questions answered by this report:
• How is the ophthalmic drugs market evolving?
• What is driving and restraining the ophthalmic drugs market?
• What are the market shares of each segment of the overall ophthalmic drugs market in 2018?
• How will each ophthalmic drug submarket grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for each ophthalmic drugs submarket develop from 2018- 2029?
• Which individual therapies will prevail and how will these shifts be responded to?
• What will be the main growth driver of the overall market from 2019-2029?
• Who are the leading players in each regional market and what are their prospects over the forecast period?
• What are the predictions for M&A activity, consolidation for existing players and the potential prospects for new market entrants?
• How will the industry evolve during the period between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the ophthalmic drugs market. You find data, trends and predictions.

Buy our report today Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029: Retinal Disorder Drugs, Allergic, Inflammatory & Infective Drugs, Glaucoma Drugs, Dry Eye Drugs.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029


Latest Pharma news

The Global Wound Care Market Is Set to Boom, Particularly in Emerging Economies

The global wound care market is big, and only set to grow bigger.  Currently, estimates show a CAGR of 4.6% in the years to come, with the overall market growing from 19.8 billion in 2019 to 24.8 billion by 2024.  The industry is ripe with opportunity, with that growth coming from several factors – but most especially growth in emerging …

30 March 2020

READ

“The global nasal drug delivery technology market is estimated to have reached $44,385 million in 2019” says new Visiongain report

Nasal Sprays segment held the largest market share of the global nasal drug delivery technology market in 2019.

30 March 2020

READ

“Global Stem Cell Technologies and Applications market set to grow to $10903.0m by 2025” says new Visiongain report

New technologies will be needed to ensure that scaling-up of manufacturing operations can be done effectively once stem cell treatments enter the market.

24 March 2020

READ

Visiongain publishes Novel Coronavirus (COVID-19) Drugs in Development Market Forecast 2020-2030 report

As per the latest reports of UNCTAD (United Nations Conference on Trade and Development), COVID-19 pandemic has not only led to tragic human consequences but is projected to cost the global economy $1 trillion in 2020.

24 March 2020

READ

Categories

Category